The preoperative hemoglobin, albumin, lymphocyte, and platelet score (HALP) as a prognostic indicator in patients with non-small cell lung cancer
The HALP index can be used as an independent prognostic factor for patients with NSCLC, offering clinicians a reference to identify high-risk patient with poor long-term prognoses and improve individualized treatment.
Authors
- Qiteng Liu
- Hong Zhao (ORCID: https://orcid.org/0000-0002-8069-9901)
- Haiying Tian (ORCID: https://orcid.org/0000-0001-6629-1021)
- Hanping Shi (ORCID: https://orcid.org/0000-0003-4514-8693)
- Heyang Zhang (ORCID: https://orcid.org/0000-0002-6047-6874)
- Tong Liu
- Chenan Liu (ORCID: https://orcid.org/0000-0001-6089-2686)
- Yue Chen (ORCID: https://orcid.org/0000-0003-4424-2098)
- Xin Zheng (ORCID: https://orcid.org/0000-0003-0915-7787)
- Xiangrui Li (ORCID: https://orcid.org/0000-0002-7143-6827)
- Xiaoyue Liu (ORCID: https://orcid.org/0000-0001-8074-3362)
- Shiqi Lin (ORCID: https://orcid.org/0009-0008-6995-2786)
- Jinyu Shi (ORCID: https://orcid.org/0000-0002-0111-2050)
- Wenjuan Cheng (ORCID: https://orcid.org/0000-0002-1113-1116)
- Hailun Xie
Institutions
- Capital Medical University (CN)
- China International Science and Technology Cooperation (CN)
- Beijing Luhe Hospital Affiliated to Capital Medical University (CN)
- Beijing Shijitan Hospital (CN)
Publication Details
- Journal
- Frontiers in Nutrition
- Published
- 2024-11-28
- DOI
- https://doi.org/10.3389/fnut.2024.1428950
- Citations
- 5
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.41
Funders
- Beijing Municipal Science and Technology Commission
- National Key Research and Development Program of China